Presented By O’Reilly and Intel Nervana
Put AI to work
September 17-18, 2017: Training
September 18-20, 2017: Tutorials & Conference
San Francisco, CA
Blake Borgeson

Blake Borgeson
Cofounder and CTO, Recursion Pharmaceuticals

Website

Blake Borgeson is the cofounder and CTO of Recursion Pharmaceuticals, where he is leading the computational development of a drug discovery platform combining high-throughput experiments and machine learning that is capable of finding potential treatments for hundreds of diseases rapidly and in parallel. Previously, he researched and built real-time navigation software for surgical procedures at the M.E. Müller Institute in Bern, Switzerland and cofounded BuildASign.com, an ecommerce company that currently employs over 350 in Austin, Texas. Blake holds a PhD in bioinformatics from UT Austin’s Marcotte Lab, where his research used machine learning to exploit new experimental techniques in rapidly mapping protein complexes, and a BS in electrical engineering from Rice University.

Sessions

11:55am–12:35pm Tuesday, September 19, 2017
Verticals and applications
Location: Imperial B Level: Beginner
Secondary topics:  Biopharmaceuticals, Deep learning
Blake Borgeson (Recursion Pharmaceuticals), Nan Li (Obvious Ventures)
Average rating: **...
(2.00, 1 rating)
Blake Borgeson and Nan Li offer a technical overview of how Recursion—a company that applies computer vision and machine learning to create a high-dimensional feature space in which to evaluate cellular health broadly across hundreds of disease states—leverages cellular phenotyping for drug discovery. Read more.